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Abstract  Tissue  storage  is  a  medical  process  that  is  in  the  regulation  and  homogenisation
phase in  the  scientiﬁc  world.
The  international  standards  require  the  need  to  ensure  safety  and  efﬁcacy  of  human  allo-
grafts such  as  skin  and  other  tissues.  The  activities  of  skin  and  tissues  banks  currently  involve
their recovery,  processing,  storage  and  distribution,  which  are  positively  correlated  with  tech-
nological  and  scientiﬁc  advances  present  in  current  biomedical  sciences.
A description  is  presented  of  the  operational  model  of  Skin  and  Tissue  Bank  at  Instituto
Nacional de  Rehabilitación  as  successful  case  for  procurement,  recovery  and  preservation  of
skin and  tissues  for  therapeutic  uses,  with  high  safety  and  biological  quality.  The  essential
and standard  guidelines  are  presented  as  keystones  for  a  tissue  recovery  programme  based  on
scientiﬁc evidence,  and  within  an  ethical  and  legal  framework,  as  well  as  to  propose  a  model
for complete  overview  of  the  donation  of  tissues  and  organ  programmes  in  Mexico.  Finally,  it
concludes with  essential  proposals  for  improving  the  efﬁcacy  of  transplantation  of  organs  and
tissue programmes.
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Banco  de  piel  y  tejidos:  un  modelo  operativo  para  la  recuperación  y  preservación  de
aloinjertos  de  piel  y  tejidos
Resumen  El  almacenamiento  de  tejido  es  un  proceso  médico  en  fase  de  regulación  y  homoge-
nización  cientíﬁca  en  el  mundo.  Los  estándares  internacionales  exigen  garantizar  la  seguridad  y
la eﬁcacia  de  los  aloinjertos  humanos  como  piel  y  otros  tejidos.  En  la  actualidad  las  actividades
de los  bancos  de  piel  y  tejidos  involucran  la  recuperación,  procesamiento,  almacenamiento  y
distribución como  proceso  de  desarrollo,  que  se  correlaciona  positivamente  con  los  avances
tecnológicos  y  cientíﬁcos  presentes  en  las  ciencias  biomédicas  actuales.
Se describe  el  modelo  instaurado  por  el  Banco  de  Piel  y  de  Tejidos  del  Instituto  Nacional
de Rehabilitación  como  un  caso  exitoso  para  la  procuración,  recuperación  y  preservación  de
piel con  ﬁnes  terapéuticos,  alta  seguridad  sanitaria  y  elevada  calidad  biológica.  Se  discuten
los fundamentos  y  estándares  empleados  en  el  programa  actual  de  recuperación  de  tejidos  con
base en  la  evidencia  cientíﬁca  disponible,  el  contexto  ético  y  el  marco  jurídico  vigente  de  la
donación de  tejidos  en  México.  Se  concluye  con  algunas  propuestas  para  mejorar  la  eﬁcacia  de
los programas  de  trasplantes.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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panorama  of  tissue  retrieval  and  storage  with  the  design
of  a  prototype  institutional  model  authorised  by  the  Banco
de  Piel  y  de  Tejidos  del  Instituto  Nacional  de  Rehabilitación
(INR)  for  retrieval  and  storage  of  high  therapeutic  value,
Table  1  Methods  for  tissue  preservation  for  transplant
uses.
Tissue  type Preservation  method
Bone  Gamma  radiation,
lyophilisation,  BR/C,  chemical
disinfection
Cartilage  Gamma  radiation,  BR/C
Tendon  Gamma  radiation,  BR/C,
chemical  disinfection
Cardiovascular  tissue
(arteries,  veins  and
cardiac  valves)
Chemical  disinfection,  BR/C
Eye tissue  (cornea,
sclera)
BR/chemical  disinfection
Skin and  dermis  Gamma  radiation,
lyophilisation,  BR/C,
decellularisation  and  chemical
disinfection
Foetal  tissues,
amnions
Gamma  radiation,
lyophilisation,  BR/C
Bone  marrow  Cryopreservation
Blood  and  blood
products
Chemical  inactivation  and
controlled  refrigerationackground
lthough  several  primitive  attempts  to  carry  out  transplants
ere  rudimentarily  described  almost  2500  years  ago,  in
he  so-called  ‘‘Sutrasthanam  manuscripts’’,1 where  they
ppeared  as  an  incipient  surgical  procedure  against  the  dam-
ge  caused  to  the  bodies  of  soldiers,  it  was  not  until  the
eginning  of  the  20th  century  that  the  ﬁrst  documented  pro-
esses  were  reported  regarding  the  use  of  tissues  preserved
t  low  temperatures  over  several  days  and  subsequently
eplanted  into  the  same  donor.2
The  Luyet3 and  Webster4 studies  documented  freezing
s  an  effective  method  for  the  temporary  preservation  of
issues.  In  accordance  with  Wright  et  al.5 Falt  and  Mar-
agonni  reported  the  ﬁrst  storage  procedures  of  skin  from
ead  bodies  using  solutions  supplemented  with  10%  serum
s  a  preserving  agent.5,6 All  these  steps  led  to  the  creation
f  a  new  type  of  establishment  from  the  end  of  the  1980s,
quipped  to  store  skin  and  other  tissues.  These  installations
ere  latterly  known  by  their  generic  name  as  ‘‘skin  banks’’.
The  use  of  human  allografts  is  closely  related  to  the
evelopment  of  different  methods  for  the  preservation  of
issues  (Table  1).  These  strategies  are  designed  to  integrate
issue  recovery  procedures  which  seek:  (1)  cellular  viabil-
ty  maintenance7;  (2)  the  preservation  of  proteins8;  (3)  the
resence  of  growth  factors  such  as:  the  epidermal  growth
actors,  the  vascular  endothelial  growth  factor,  the  trans-
orming  growth  factor  beta  and  pro-inﬂammatory  cytokines
Il-2,  Il-6,  Il-10  TNF- alfa);  and  (4)  the  complete  integrity  of
issues.  All  these  factors  focus  on  generating  biological  prod-
cts  of  high  quality,  with  top  health  safety  and  of  extreme
herapeutic  value.9
The  procurement  and  preservation  of  tissues  is  a  rapidly
nd  increasingly  developed  activity  which  is  positively  cor-
elated  with  technological  and  scientiﬁc  advances  present  in
iomedical  sciences  during  the  20th  century.  Furthermore,
emand  for  allografts  for  therapeutic  reasons  is  projected
o  increase  considerably  as  a  result  of  the  increase  inife  expectancy  and  its  concomitant  increase  in  chronic
egenerative  diseases.  The  design  of  successful  institutional
trategies  capable  of  promoting  donation  activities  and  tis-
ue  retrieval10--12 has  therefore  become  imperative.
The  aim  of  our  study  consisted  of  describing  the  currentGerm  cells  Cryopreservation
BR/C, biological recovery and cryopreservation.
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thanks  to  the  use  of  scientiﬁc  principals  applied  to  self  sus-
tainability  of  the  health  system  needs  in  Mexico.
Worldwide  regulation  of  skin  banks
Several  international  associations  which  promote  protocols
and  directives  for  the  technical  operation  of  skin  and  tissue
banks13--16 were  created  in  order  to  organise  establishment
and  operations.  The  following  are  of  note:  (1)  American
Association  of  Tissue  Banks,  created  in  1972;  (2)  Euroskin
Bank  (Bewerjwick,  NL)  founded  in  1976  and  called  Tissue
Bank  from  2010;  (3)  European  Association  of  Tissue  Banks,
established  in  1991;  (4)  Asociación  Espan˜ola  de  Bancos  de
Tejidos,  founded  in  2002;  (5)  Asociación  de  Bancos  de  Teji-
dos  de  Asia-Pacíﬁco;  and  (6)  la  Asociación  Latinoamericana
de  Bancos  de  Tejidos.
All  these  organisations  try  to  regulate  the  standardisation
of  directives  for  the  therapeutic  storage  and  use  of  tissues
for  transplant,  in  conjunction  with  other  governmental,  eth-
ical  and  scientiﬁc  bodies.  The  following  central  points  may
be  highlighted  from  the  international  standards:  (1)  ethical
aspects  regarding  the  procurement  of  tissues  based  on  altru-
ism  and  not  trading;  (2)  regional  regulation  of  prevailing
health  laws;  (3)  administrative  organisation;  (4)  standards
for  physical  installations  of  tissue  banks;  (5)  recuperation  of
tissues  with  pharmaceutical  quality  and  standards;  and  (6)
traceability  of  preservation  processes.
Tissue  banks  in  Mexico
In  the  Mexican  Republic  initial  activities  related  to  tissue
storage  were  made  with  bone  material.  Pioneering  proce-
dures  took  place  in  the  Hospital  Central  Militar  and  the
Hospital  Infantil  de  México  in  1944.  During  the  1950s  sim-
ilar  activities  were  initiated  in  Hospital  Rubén  Len˜ero  and  in
Hospital  Regional  de  Monterrey.
In  1997  the  Hospital  Central  de  Petróleos  Mexicanos  and
the  Universidad  Nacional  Autónoma  de  México  carried  out
several  procedures  relating  to  tissue  storage,  using  the  then
available  international  standards.  The  Banco  de  Tejidos  of
the  Instituto  Nacional  de  Investigaciones  Nucleares  (ININ)
is  prominent  here  as  it  began  to  use  gamma  radiation  to
sterilise  bone  tissues,  pig  hide  and  amniotic  membranes.
Activities  in  Skin  and  Tissue  Banks  today  involve  the  pro-
curement,  processing,  storage  and  distribution  of  biological
products  classiﬁed  by  the  current  Ley  General  de  Salud  as
‘‘biological  supplies’’  as  they  include  an  industrialisation
process  which  guarantees  their  safety  and  efﬁcacy.
On  30th  January  2013  the  national  register  of  the  Centro
Nacional  de  Trasplantes  recorded  56  establishments  classed
as  Banks,  which  were  regulated  jointly  with  the  Comisión
Federal  de  Protección  contra  Riesgos  Sanitarios  (COFEPRIS).
Legal  framework  of  tissue  banks  in  Mexico
The  Sistema  Nacional  de  Trasplantes  (SNT)  is  a  structure
located  within  the  Sistema  Nacional  de  Salud,  consisting  of
all  the  establishments  and  hospitals  possessing  a  licence  to
carry  out  organ  or  tissue  donor  transplant  activities  and  cell
or  tissue  bank  activities  authorised  by  COFEPRIS.  All  these
bodies  are  subject  to  the  regulations  established  by  law  and
r
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peciﬁcally  that  laid  down  in  Title  XIV  of  Ley  General  de
alud,  in  the  legal  regulations  issued  on  these  matters  and
ther  directives.13
In  compliance  with  prevailing  legislation,  the  Skin  and
issue  Bank  of  the  Instituto  Nacional  de  Rehabilitación  is
uthorised  to  offer  organs,  tissues  and  cells  for  transplant,
hrough  organ,  tissue  extraction,  skin  and  muculoskeletal
issue  transplant,  and  also  a  tissue  bank  (skin  and  muscu-
oskeletal  tissue).  The  legal  context  enables  the  Skin  and
issue  Bank  to  have  an  innovative  and  far-reaching  approach
n  its  procedures  model  for  procurement,  preservation  and
ransplant  of  tissues  for  therapeutic  purposes.  This  approach
ncludes  social  aspects  for  the  promotion  of  an  organ  and
issue  donor  culture  and  the  training  of  highly  specialised
uman  resources  in  donor  and  tissue  preservation  matters.
he  transplant  Committee  as  a regulating  body  of
exican  bank  activities
he  corner  stone  of  the  SNT  are  the  Internal  Transplant  Com-
ittees  in  each  hospital.  In  compliance  with  article  316  of
he  Ley  General  de  Salud,  these  collegiate  bodies  comprise
 health  care  director  and  a  group  of  health  professionals
ho  are  experts  in  this  sector,  coordinators  in  donation  and
ransplant,  and  the  necessary  administrative  support  staff
or  these  procedures.13,17
Although  in  the  strict  sense  of  the  word,  the  main  func-
ion  of  a  bank  is  to  safeguard  tissues  until  use,  this  activity
hould  be  secondary  to  the  development  of  preservation
ctivities  with  traceability  of  transparency  and  safety  for
perators  and  users.  The  supervision  of  these  activities  was
ntrusted  to  the  Comisión  Federal  para  la  Protección  contra
iesgos  Sanitarios  (COFEPRIS).
roblems  with  skin  and  tissues  banks  in  Mexico
ue  to  the  existing  lag  in  adopting  this  type  of  establish-
ent  the  following  problems  arise  in  Mexico:  (1)  there  is
ittle  experience  in  the  practise  of  tissue  storage;  (2)  a  high
earning  curve  exists  and  high  costs  associated  with  spe-
iﬁc  training  in  this  area;  (3)  there  is  no  active  training
nd  educational  programme  for  the  culture  of  organ  and
issue  donation;  (4)  no  integrated  model  of  donation,  pro-
urement  and  cadaveric  skin  processing  exists  within  the
istema  Nacional  de  Salud;  (5)  there  is  very  little  ﬁnancial
nvestment  in  scientiﬁc  research  aimed  at  tissue  storage;
6)  there  are  problems  derived  from  current  legislation  and
lassiﬁcation  of  biological  tissues  as  ‘‘supplies’’  in  the  Ley
eneral  de  Salud;  (7)  private  companies  are  competing  for
issue  donation;  (8)  the  health  sector  lacks  any  industrial
evelopment  for  the  generation  of  supplies;  (9)  ethical  prob-
ems  arise  derived  from  private  banks  competing  for  donors,
hrough  practices  which  lack  sufﬁcient  regulation.
he  Skin  and  Tissue  Bank  of the  Instituto  Nacional
e Rehabilitación  as  a prototype  model  for  the
ecuperation of  tissues
ince  March  2009,  the  Skin  and  Tissue  Bank  of  the  Instituto
acional  de  Rehabilitación  has  been  the  Ministry  of  Health’s
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Network of procuring hospitals:
• INNyN MVS. Juárez, México
• H. Juárez de México.
•  H. General de México.
• Hospital Infantil de
México.
• Instituto Nacional de
Pediatria.
• Instituto Mexicano del
Seguro Social. Centro Médico
 Nacional Siglo XXI.
Procuring hospital Skin and tissue bank Requesting unit
Processing and
recuperation
Liberation
Certified storage 
Cryopreservation Quarantine
Follow-up
Surgical
procurement
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on  iodine  and  alcohol  solutions  in  different  concentrations
(70--100%),  in  a  surgical  area  with  an  aseptic  technique.
Table  2  Inclusion  and  exclusion  criteria  for  organ  and  tis-
sue donation.
General  criteria  for  organ
donation  candidates
General  criteria  for  tissue
donation  candidates
Encephalic  death  certiﬁed
for  cadaveric  donor
Encephalic  death  or
certiﬁcation  of  loss  of  life
Certiﬁcation  of  loss  of  life  Negative  serology  for:  HIV  1
and  2,  HBV,  HCV  and  HLV
and  VDRL
No signiﬁcant  history  of
disease  which  affects
the  organ  to  be
donated
No  history  of  major  disease
that  affects  tissues  under
consideration
No  uncontrolled  septic
process
Leucocytes  under  15,000/dl
No history  of  extra  cranial
malignancy
No  clinical  history  of
autoimmune  diseases
Relative  haemodynamic Consider  speciﬁc  exclusionigure  1  Operational  model  of  the  Skin  and  Tissue  Bank  of  th
acional de  Neurología  y  Neurocirugía;  MVS,  Manuel  Velasco  Su
eading  tissue  bank  in  tissue  storage,  within  the  framework
f  National  Health  Institutes.  Its  mission  is  to  be  a  centre
f  excellence  in  the  procurement,  processing  and  storage  of
kin  and  other  tissues,  through  the  development  of  a  model
ased  on  scientiﬁc  research,  the  use  of  new  biomedical  and
olecular  state-of-the-art  technologies  and  the  education
nd  training  of  highly  specialised  human  resources.
In  addition,  the  bank  provides  specialised  surgical  assis-
ance  for  the  obtention  of  tissues  in  procurement  hospitals
r  those  generating  procurement,  as  well  as  their  use  in  allo-
enic  tissue  implantation  programmes.  At  the  same  time  it
evelops  donor  culture  awareness  and  outreach  campaigns.
The  bank  reiterates  the  directives  and  principles  estab-
ished  by  the  Centro  Nacional  de  Trasplantes  with  the
ntroduction  of  5  essential  ethical  principles:  voluntary
onation,  altruism,  solidarity,  conﬁdentiality  and  informa-
ion.
tandards  of  the  Skin  and  Tissue  Bank  for  the
arvesting of  skin  and  tissue  allografts  for  use  in
ransplants
he  model  followed  by  the  Skin  and  Tissue  Bank  of  the  and
nstituto  Nacional  de  Rehabilitación  is  based  on  complete
ntegration  of  the  phases  involved  in  the  tissue  donation
nd  transplant  system,  with  traceability  outlined  for  the
rocedures  in  line  with  ISO-9000-2008  (Fig.  1)  regulation.
arvestinghe  procedure  for  obtaining  skin  and  tissues  is  made
hrough  inter-institutional  collaboration  with  different
ransplant  programmes  which  meet  the  criteria  established
or  organ  and  tissue  donation  (Table  2).  Tissue  harvestingtituto  Nacional  de  Rehabilitación.  H,  hospital;  INNyN,  Instituto
s  currently  deﬁned  as  a  surgical  event  (Fig.  2) and  as  such
uality  standards  for  skin  recovery  surgery  must  therefore
e  adhered  to.18
Once  informed  consent  has  been  obtained  from  the  mul-
iple  organ  donor’s  family  and  cardiac  arrest  meets  with
nclusion  criteria  (Table  3),  in  the  speciﬁc  case  of  skin
urface  area  disinfection  processes  are  carried  out  basedstability criteria  per  tissue
VDRL, serological test for syphilis; HBV, hepatitis B virus; HCV,
hepatitis C virus; HIV, human immunodeﬁciency virus; HLV,
human lymphotropic virus.
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Table  3  Essential  directives  for  the  recovery  of  tissues.
Strict  control  and  assessment  of  potential  donors
Quality  control  of  tissue  surgical  procurement  sites
Systematised  procedure  for  recovery  of  the  cellular
viability  of  tissues  based  on  scientiﬁc  proof
Microbiological  ﬁnal  product  certiﬁcation
Preservation  of  physical  and  chemical  characteristics  and
biological  properties  of  tissues
Molecular  certiﬁcation  of  donors  and  tissues,  based  on
molecular  tests  to  reduce  the  waiting  time  periods  for
generation  of  a  antigen-antibody  response  (PCR,  PCR  in
real time)
Traceability  of  processes
Ethical  criteria  in  donation,  based  on  altruism  and  non
commercialisation
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isms  identiﬁcation  is  to  take  readings  at  7,  14  and  21  days
under  speciﬁc  mediums.19 The  microbiological  control  sys-Figure  2  Surgical  procurement  of  skin.
Recovery  and  preservation
The  concept  of  recovery  focuses  on  reversing  or  as  much
slowing  down  as  possible  of  cell  death,  induced  by  tissue
hypoxy  and  the  depletion  of  nutrients,  after  the  last  heart-
beat.  To  do  this  the  tissues  are  stored  in  solutions  formulated
with  a  physiological  pH  (7.4)  and  with  buffering  agents  in  the
presence  of  essential  nutrients  and  antibiotics  to  begin  the
process  of  microbial  decontamination.  Medium  term  preser-
vation  is  achieved  using  cryopreserving  solutions  and  pH
stabilisers  which  enable  the  tissue  to  be  maintained  at  a
temperature  below  −80 ◦C.  The  formulation  of  these  mate-
rials  is  carried  out  in  the  preparation  laboratory  of  the  tissue
and  skin  bank  itself,  in  keeping  with  the  good  manufacturing
t
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Figure  3  Health  certiﬁcation  model  for  skin  and  tissues.  CMV,  cyto
of immunodeﬁciency;  VHB,  hepatitis  B  virus;  VHC,  hepatitis  C  virus.PCR, polymerase chain reaction.
ractice  and  good  laboratory  practice,  and  are  sterilised  by
ltration.
icrobiological  quality  certiﬁcation
he  biological  quality  of  the  tissues  and  the  microbiological
ertiﬁcation  are  essential  standards  for  tissue  preservation.
he  standard  for  aerobic,  anaerobic  and  fungal  microorgan-em  is  used  in  tissue  quality  control  protocols,  with  the  use
f  solution  to  maintain  contact  with  the  recuperation  and
reservation  process  (Fig.  3).
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This  point  necessitates  a change  in  the  conceptualisation  of
the  obtainment  of  tissues  as  a  surgical  event,  with  particularigure  4  Polymerase  chain  reaction  in  real  time  for  the
olecular  certiﬁcation  of  skin  and  tissues.
olecular  biology  techniques  for  identiﬁcation  of
athogen  agent  identiﬁcation
he  gold  standard  in  identifying  pathogens  is  carried  out
ith  the  identiﬁcation  of  genomic  segments  using  the  poly-
erase  chain  reaction  technique  (PCR).  This  technique
hich  was  described  by  Kubista  Mullis  and  his  team20 has
 sensitivity  rate  of  1  ×  10−7;  i.e.  it  is  able  to  identify
n  infected  cell  for  every  1  ×  107 healthy  cells.  In  the
ase  of  certiﬁcation  protocols,  the  tests  which  the  banks
erform  are  made  in  real  time,  searching  for  the  human
mmunodeﬁciency  virus  types  1  and  2,  hepatitis  B  and  C;
ytomegalovirus  and  Treponema  pallidum.  Given  that  the
echnique  is  highly  speciﬁc  and  sensitive,  tests  are  made  in
riplicate  in  a  sterilised  area  and  safety  cabinet  with  lami-
ar  ﬂow  type  II-AB.  These  tests  are  validated  for  diagnostic
nd  clinical  use  in  humans  and  include  internal  controls  (cal-
brated  as  negative  and  positive)  for  each  test  with  a  search
n  donor  blood  and  tissue  (Fig.  4).6,20
hysical  infrastructure
t  present  the  bank  consists  of  5  laboratories,  which  meet
ith  class  100  regulations  and  operate  according  to  good
anufacturing  practice  and  good  laboratory  practice.  Since
his  is  a  national  reference  centre,  the  bank  used  its  physical
nfrastructure  meeting  with  directives  from  the  Federación
span˜ola  de  Bancos  de  Tejidos  and  the  Asociación  Europea  de
ancos  de  Tejidos.  It  is  physically  structured  according  to  3
ain  areas10:  (1)  class  100  inner  chamber;  (2)  administrative
rea;  and  (3)  support  and  research  areas.
lass  100  inner  chamber  structure
aboratory  for  the  preparation  of  materials
quipment  and  materials  for  the  preparation  of  cleans-
ng,  decontamination  and  maintenance  solutions  at  constant
emperature  (18 ◦C),  ﬁltered  air  (class  100)  and  positive
ressure.
e
l
t
2F.  Martínez-Flores  et  al.
uarantine  laboratory
lean  room  with  constant  temperature  (18 ◦C),  ﬁltered  air
class  100)  and  positive  pressure  for  recovery  and  decontam-
nation  of  tissues.  Refrigerators  for  maintaining  a  constant
emperature  (4 ◦C)  in  decontamination  processes.  Class  IIAB
iological  safety  cabinet  for  handling  tissue.
rocessing  laboratory  for  musculoskeletal  tissue
ouble-chamber  clean  room  insulated  with  a  constant  tem-
erature,  ﬁltered  air  (class  100)  and  positive  pressure  aimed
t  the  recovery,  cutting  and  decontamination  of  muscu-
oskeletal  tissue.
ackaging  laboratory
lean  room  with  constant  temperature  (18 ◦C),  ﬁltered  air
class  100)  and  positive  pressure,  for  ﬁnal  tissue  packaging
rior  to  being  sent  for  ﬁnal  freezing.  The  processes  are  car-
ied  out  in  a  class  IIA-B  biological  safety  cabinet  for  tissue
anding.  The  inner  chamber  connects  with  an  area  for  tissue
torage  and  safekeeping.
issue  storage  and  safekeeping  area  (deep  freezing)
estricted  access  area  for  tissue  storage  with  tempera-
ure  support  systems,  monitoring  system  in  real  time  for
emperature  recording  and  a  televised  surveillance  system.
onstant  temperature  (18 ◦C)  and  class  100  ﬁltered  air.
quipment  and  Sterilisation  Centre  (CEYE)
quipment  and  supplies  for  validating  sterilisation  processes
f  materials  and  equipment  used  in  procurement  processes.
dministrative  area
esigned  outside  central  facilities  and  with  restricted
ccess.
upport  and  research  areas
onstituted  by  a  laboratory  of  multiple  uses  and  with  a
ulture  chamber,  for  the  development  of  research  proto-
ols  relating  to  the  formulation  of  materials,  cellular  death
lockage  mechanisms  and  cryobiotic  molecular  strategies
or  the  purpose  of  transplants.
iscussion and perspectives
n  keeping  with  the  worldwide  trend  to  recuperate  tissues
or  therapeutic  uses,  the  storage  of  skin  and  other  tissues  in
he  context  of  healthcare  needs  and  current  Mexican  medi-
al  research  several  of  the  following  points  must  be  precisely
eﬁned  to  obtain  a  better  therapeutic  outcome:
onceptualise  the  procurement  and  harvesting  of
issues as  a surgical  eventmphasis  on  quality,  as  recently  described  in  detail  in  the
asts  amendment  to  the  Ley  General  de  Salud,  relating  to
he  regulation  governing  organs  and  tissues  (12th  December
011).
Skin  and  tissue  bank:  Operational  model  for  the  recovery  and  pr
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FFigure  5  Meshed  human  skin  allograft  recovered  for  trans-
plant uses.
Deﬁning  the  type  of  procedure  used  in
preservation
Each  method  (chemical  decontamination,  lyophilisation,
gamma  sterilisation)  has  a  different  effect  on  the  biological,
physical  and  chemical  characteristics  of  the  tissue  (cellular
viability  index,  loss  of  water,  of  elasticity  and  resistance),
and  ﬁnally,  in  its  posterior  usage.  In  our  model  the  prelimi-
nary  data  indicate  that  the  biological  recuperation  of  tissues
represents  the  method  with  the  best  therapeutic  outcome,
following  a  long  period  of  freezing  at  temperatures  below
80 ◦C  below  zero  (Fig.  5).
Traceability  of  processes
Documentation  of  each  phase  of  procurement,  preservation
and  liberation  of  tissue,  respecting  privacy  and  conﬁdential-
ity  data.
The  traceability  of  processes  must  document  the  critical
route  of  each  process  and  include  essential  documents  such
as:  (1)  manual  for  speciﬁc  procurement  procedure;  (2)  man-
ual  for  speciﬁc  procedure  for  recuperation  and  preservation
of  tissues;  (3)  manual  for  microbiological  control  and  speciﬁc
tissue  quality;  (4)  procurement  protocol  for  tissue  procuring
hospitals;  (5)  clinical  ﬁles  and  service  formats  (microbio-
logical,  molecular  laboratory,  pathology,  etc.);  (6)  manual
and  records  of  preventative  maintenance  of  equipment  and
installations;  (7)  registry  and  control  of  access  for  general
services  and  microbiological  records  of  environmental  con-
trols;  and  (8)  registry  and  report  of  activities  sent  to  the
Centro  Nacional  de  Trasplantes.
In  addition,  the  following  lines  of  action  may  have  a  seri-
ous  impact  on  the  growth  of  tissue  bank  activity:
Integration  and  growth  of  a hospital  network  for
increasing regional  tissue  afﬂuenceEstablishing  a  network  for  the  procurement  of  tissues
involves  carrying  out  a  large  number  of  collaboration  agree-
ments  in  tissue  procurement  matters,  for  transplant  in  other
T
n
Seservation  91
ospital  institutions,  for  the  purpose  of  increasing  the  iden-
iﬁcation  of  potential  tissue  donors.
mplementation  of  a  research  programme  in  tissue
harmaceutical cryobiotics  with  therapeutic  uses
he  aim  of  this  is  to  promote  the  design  of  procure-
ent  and  cryopreservation  protocols  for  skin  and  tissues,
nd  also  to  foster  the  broadening  of  scientiﬁc  research
o  reduce  dependency  on  imported  materials  and  promote
elf-sustainability  of  operations,  focused  on:  (1)  scientiﬁc
rocedures  for  preservation  and  tissue  cryobiology  aimed  at
btaining  high  quality  biological  and  therapeutically  effec-
ive  products;  (2)  generation  of  materials  and  patents  for  the
ank’s  self  sustainability;  and  (3)  scientiﬁc  dissemination  of
rocesses  used  in  other  institutions.
mplementation  of  an  academic  surgical  training
rogramme for  tissue  procurators
rranging  the  registration  and  execution  of  multi-tissue
rocurator  courses,  endorsed  by  both  academic  institutions
nd  the  Centro  Nacional  de  Trasplantes  In  Mexico  to  form
pecialised  and  highly  trained  personnel.  Furthermore,  to
nclude  speciﬁc  modules  on  the  surgical  procedures  involved
n  tissue  procurement  and  transplant  in  pre-grade  modules
tudy  programmes.
dvocacy  of  a  more  widespread  cadaveric  skin
onation culture
riving  the  training  programme  for  leaders  who  will  be
he  promoters  of  the  culture  of  organ  and  tissue  donation
n  collaboration  with  non-governmental  organisations  and
ass  media  communication  campaigns,  with  use  of  social
etworks  and  internet.
Last  but  not  least,  several  ethical  considerations  have  to
e  readdressed,  starting  with  the  fact  that  the  obtainment
f  tissues  is  an  act  of  altruistic  donation  with  no  proﬁt  mak-
ng  or  commercialisation  and  process  recuperation  quotas
ust  therefore  be  regulated  and  deﬁned;  this  point  is  also
eing  addressed  by  the  World  Health  Organisation.
The  coordination  and  integration  of  the  organ  and  tis-
ue  donation  and  transplant  programmes  must  be  carried
ut  with  functional,  responsible  and  equitable  participation
rom  areas  of  research,  human  resources  training  and  health
are  services.
This  model  is  merely  one  of  the  medium  term  propo-
als  to  modify  the  current  tissue  recovery  setting.  Possibly
n  a  couple  of  decades,  similarly  to  the  Spanish  model  it
ould  become  the  world  leader  of  organ  and  tissue  donor
rogrammes.
inancinghis  study  was  ﬁnanced  by  the  Council  for  Science  and  Tech-
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